It is a chemicals and materials private limited company based in Indore, Madhya Pradesh, India, established in 2018.
2018 | Indore, Madhya Pradesh, India | ActiveMark-India Biologicals Private Limited, a active private limited company, was established on 28 May 2018 in Indore, Madhya Pradesh, India. Engaging in petrochemicals & derivatives within the chemicals and materials sector, it holds CIN: U24290MP2018PTC045907. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Imran Abdul Rehman Shaikh (Director), Anilkumar Chaturgun Maurya (Director), Faheem Sameer Khan (Director). Past directors included Anil Maloo. Its latest AGM occurred on 27 September 2019, with the balance sheet filed on 31 March 2019. It is based at Flat No.203, 2Nd Floor, Plot No. 421, Kalakriti Corner Building, Goyal Nagar, Indore, Madhya Pradesh, 452010.
U24290MP2018PTC045907
045907
28 May 2018
₹0.10 M
₹0.10 M
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Mark-India Biologicals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Imran Abdul Rehman Shaikh | Director | 07 Jul 2020 | Current |
| Anilkumar Chaturgun Maurya | Director | 28 May 2018 | Current |
| Faheem Sameer Khan | Director | 07 Jul 2020 | Current |
| Niraj Singh | Director | 15 Feb 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Jul 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mark-India Biologicals Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2019, Mark-India Biologicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Mark-India Biologicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mark-India Biologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mark-India Biologicals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Niraj Singh was appointed as a Director was appointed as a Director on 15 Feb 2023 & has been associated with this company since 2 years 9 months . was documented.
The activity Imran Abdul Rehman Shaikh was appointed as a Director was appointed as a Director on 07 Jul 2020 & has been associated with this company since 5 years 4 months . was completed.
Faheem Sameer Khan was appointed as a Director was appointed as a Director on 07 Jul 2020 & has been associated with this company since 5 years 4 months . was recorded as a recent event.
Mark-India Biologicals Private Limited last Annual general meeting of members was held on 27 Sep 2019 as per latest MCA records. was recorded as a recent event.
Progress on Mark-India Biologicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Gwalior. was documented.
Progress on Anilkumar Chaturgun Maurya was appointed as a Director was appointed as a Director on 28 May 2018 & has been associated with this company since 7 years 5 months . was documented.
The CIN of Mark-India Biologicals Private Limited is U24290MP2018PTC045907.
Mark-India Biologicals Private Limited is headquartered at Flat No.203, 2Nd Floor, Plot No. 421, Kalakriti Corner Building, Goyal Nagar, Indore, Madhya Pradesh, 452010.
Mark-India Biologicals Private Limited was incorporated on 28 May 2018.
The current directors of Mark-India Biologicals Private Limited are
The primary industry of Mark-India Biologicals Private Limited is Chemicals And Materials.
Mark-India Biologicals Private Limited is unlisted.
The authorized capital of Mark-India Biologicals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX